EICHORCondition: Pneumonia · Hypoxemia · Acute Respiratory Failure · Sponsor: Stanford University
This research study seeks to establish the effectiveness of a combination of an inhaled corticosteroid and a beta agonist compared to placebo for the prevention of acute respiratory failure (ARF) in hospitalized patients with pneumonia and hypoxemia.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| University of Alabama Birmingham - Main & Highlands | Birmingham, Alabama, United States | — |
| Mayo Clinic - Scottsdale | Scottsdale, Arizona, United States | — |
| University of Arizona - Main & South Campus | Tucson, Arizona, United States | — |
| Stanford University | Palo Alto, California, United States | — |
| University of Florida | Gainesville, Florida, United States | — |
| Mayo Clinic - Jacksonville | Jacksonville, Florida, United States | — |
| Tulane University - Main & BUMC | New Orleans, Louisiana, United States | — |
| University of Maryland | Baltimore, Maryland, United States | — |
| Johns Hopkins University - Main Campus & Bayview | Baltimore, Maryland, United States | — |
| Mayo Clinic - Rochester | Rochester, Minnesota, United States | — |
| New York University - Langone Health | New York, New York, United States | — |
| Temple University | Philadelphia, Pennsylvania, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04193878